Prevention of blood disorders in patients treated with a PPAR agonist

CO20260013137A2Pending Publication Date: 2026-09-28INVENTIVA

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CO20260013137
Authority / Receiving Office: CO · CO
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-03-14
Filing Date: 2026-09-10
Publication Date: 2026-09-28

Application Information

Patent Timeline

14 Mar 2025

Priority

10 Sep 2026

Application

CO20260013137

28 Sep 2026

Publication

CO20260013137A2

IPC: A61K31/428; A61K31/382; A61K31/7034; A61K31/7042; A61K31/7048; A61K31/7056; A61K45/06; A61P3/00; A61P7/00; A61P7/06

CPC: A61K31/7048; A61K31/428; A61K31/382; A61K31/7034; A61K31/7042; A61K31/7056; A61K45/06; A61P7/06

Inventors: BROQUA Pierre; HUOT-MARCHAND Philippe

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to the use of sodium glucose transporter 2 (SGLT2) inhibitors for the prevention or delay of clinical complications of blood disorders, preferably anemia or clinical complications of anemia, in patients who have been treated, are being treated, or are planned to be treated with a PPAR agonist.

Need to check novelty before this filing date? Find Prior Art